OrthoPediatrics (KIDS) Reports In-Line Q2 EPS

OrthoPediatrics (NASDAQ: KIDS) reported Q2 EPS of ($0.26), in-line with the analyst estimate of ($0.26). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $52.52 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• BofA Securities Upgrades Humana (HUM) to Buy, 'The path to $45 EPS power by 2028'
• Essential Properties Realty Trust (EPRT) PT Raised to $37 at Cantor Fitzgerald on Sector-Leading Earnings Growth
• Frontier Group Holdings, Inc. (ULCC) Tops Q2 EPS by 39c